Digoxin Versus Ivabradine in Heart Failure With Preserved Systolic Function (DIGvsIVA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01796093|
Recruitment Status : Completed
First Posted : February 21, 2013
Last Update Posted : February 1, 2017
Cocco, Giuseppe, M.D.
Cardiology Office, Rheinfelden, Switzerland
Information provided by (Responsible Party):
Cocco G., M.D., Cocco, Giuseppe, M.D.
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||February 2012|
|Actual Study Completion Date :||February 2012|
Publications of Results:
Cocco G, Jerie P. Comparison of digoxin and ivabradine in heart failure with preserved systolic function. Submitted to the American Heart Journal.